Related Experiment Videos
Kunitz-type inhibitors in human serum. Identification and characterization.
The Journal of Biological Chemistry
|March 15, 1987
Summary
Researchers identified two Kunitz-type protease inhibitors in human serum. These inhibitors are homologous to pancreatic trypsin inhibitors and may regulate blood clotting and fibrinolysis.
Area of Science:
- Biochemistry
- Proteomics
Background:
- Human serum contains low concentrations of protease inhibitors.
- Kunitz-type inhibitors are known for their role in regulating proteolytic enzymes.
Purpose of the Study:
- To purify and characterize two low molecular weight, basic Kunitz-type protease inhibitors from human serum.
- To investigate their homology to known inhibitors and their potential physiological roles.
Main Methods:
- Affinity chromatography using immobilized trypsin.
- Ion-exchange chromatography within a fast protein liquid chromatography (FPLC) system.
- Chemical, immunochemical, and functional property analysis.
Main Results:
- Two homologous Kunitz-type protease inhibitors were successfully purified from human serum.
- The purified inhibitors exhibited high homology to basic pancreatic trypsin inhibitors found in bovids and caprids.
- Inhibitory activity was observed against serine proteases like plasmin and kallikrein.
Conclusions:
- The purified human serum inhibitors are closely related to known Kunitz-type pancreatic trypsin inhibitors.
- These inhibitors may play a regulatory role in crucial physiological processes such as blood clotting and fibrinolysis.